Pharmaceutical відкриті
[search 0]
більше
Download the App!
show episodes
 
Artwork

1
Pharmaceutical Executive

Pharmaceutical Executive Podcast

Unsubscribe
Unsubscribe
Щомісяця+
 
The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and http://PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.
  continue reading
 
DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Use cases for the DrugPatentWatch platform include: - Branded pharmaceutical global business intelligence and forecasting - Generic drug and API manufacturer portfolio management - Wholesalers preventing overstock of off-patent drugs - Healthcare payer formulary management and budget management
  continue reading
 
Welcome to the Biotech Bytes podcast, where we sit down with Biotech and Pharma IT leaders to learn what's working in our industry. Steven Swan is the CEO of The Swan Group LLC. He has 20 years of experience working with companies and individuals to make long-term matches. Focusing on Information technology within the Biotech and Pharmaceutical industries has allowed The Swan Group to become a valued partner to many companies. Staying in constant contact with the marketplace and its trends a ...
  continue reading
 
Loading …
show series
 
In this week’s episode, in recognition of international women’s month, Editor Miranda Schmalfuhs has compiled audio clips from interviews with female KOLs that she's been fortunate enough to speak with over this past month for content across a few of our brands. Featured in this episode are: Emma Banks, CEO, ramarketing Jill Jaroch, Senior Director…
  continue reading
 
The intersection of healthcare and technology paves the way for revolutionary patient care, shaping the future with precision and personalization. Today, the spotlights are on how getting data ready for AI applications is changing the game in healthcare. I'm thrilled to welcome Christopher J Kouzios, the Principal Owner of Kooz Technologies, an exp…
  continue reading
 
Nashville SC suffered their worst defeat in club history against LAFC over the weekend. The team will have to turn it around quickly with MLS Cup defending Champions Columbus Crew coming to town. As always, thanks for listening!Pharmaceutical Soccer
  continue reading
 
A recent article in Communications of the ACM explores opportunities for “Permissionless innovation” in pharmaceuticals. “Permissionless innovation” refers to the freedom to explore new technologies or businesses without needing prior…SourceDrugPatentWatch
  continue reading
 
Ian Baer, Founder and Chief Soothsayer, Sooth, discusses their recent data and research about some massive behavioral shifts occurring across Gen-Z, and how pharmaceutical companies and healthcare advertising agencies can adapt their strategies to attract the ever elusive generation.Pharmaceutical Executive Podcast
  continue reading
 
How do we navigate the complexities of workforce management in the era of artificial intelligence? Today's discussion sheds light on the intricacies of HR policies as they adapt to the technological advancements in AI. I’m joined by Bill Pierce, Chief Information Officer at BioIVT, a visionary in leveraging technology to enhance business processes.…
  continue reading
 
Oncolytic virotherapy, an innovative approach leverages the natural ability of viruses to infect and kill tumor cells, offering a beacon of hope for patients battling cancer. Our journey through this domain uncovers the mechanisms of action of oncolytic viruses, explores representative examples, discusses strategic modifications and combinations wi…
  continue reading
 
LACTOSE-Free Medicines, 2024 is part of DrugPatentWatch’s deep library of business intelligence on biopharmaceutical drugs. Buy Lactose-Free Medicines from Amazon This guide is designed to provide information for healthcare providers to…SourceDrugPatentWatch
  continue reading
 
GELATIN-Free Medicines, 2024 is part of DrugPatentWatch’s deep library of business intelligence on biopharmaceutical drugs. Buy Gelatin-Free Medicines on Amazon This guide is designed to provide information for healthcare providers to…SourceDrugPatentWatch
  continue reading
 
Creative Biolabs integrates the latest scientific advances in exosomes and makes them into a podcast column. This episode introduces the exosome biogenesis and therapeutics knowledge.antibodybasedpharmaceuticalsresourcelibrary
  continue reading
 
Creative Biolabs integrates the latest scientific advances in exosomes and makes them into a podcast column. This episode introduces the exosome biogenesis and therapeutics knowledge.antibodybasedpharmaceuticalsresourcelibrary
  continue reading
 
Creative Biolabs integrates the latest scientific advances in exosomes and makes them into a podcast column. This episode introduces the exosome biogenesis and therapeutics knowledge.antibodybasedpharmaceuticalsresourcelibrary
  continue reading
 
Creative Biolabs integrates the latest scientific advances in exosomes and makes them into a podcast column. This episode introduces the exosome biogenesis and therapeutics knowledge.antibodybasedpharmaceuticalsresourcelibrary
  continue reading
 
The impact of AI on data management, particularly in the realm of biotechnology, is undeniable. It has fundamentally transformed how we approach and utilize vast amounts of data in this field. Joining me is Elisabeth Schwartz, the IT Head at Phathom, to explore the crucial task of preparing data for AI applications and the hurdles we face in ensuri…
  continue reading
 
Switching pharmaceutical excipients, the inactive components used in drug formulations, can have significant implications for both production costs and market appeal. These components, while not contributing directly to the therapeutic…SourceDrugPatentWatch
  continue reading
 
This video provides a comprehensive overview of lipid nanoparticle-based mRNA Vaccine development, detailing the technological timeline, the 2023 Nobel Prize-winning science behind the vaccines, and the specifics of COVID-19 vaccine candidates BNT162b2 and mRNA-1273. It also explores the advantages of liposomes in mRNA delivery, the intricate mecha…
  continue reading
 
Elevate your excipient business strategies with the comprehensive Drug Excipient Business Development Reports from DrugPatentWatch. Designed for excipient manufacturers seeking lucrative opportunities in the pharmaceutical industry, these reports offer invaluable…SourceDrugPatentWatch
  continue reading
 
The convergence of technology and business savvy is reshaping the biotech landscape. Today's leaders are adept at harnessing IT to drive profitability and impact lives, turning data and innovation into strategic gold. In this episode, I sit down with Eduard De Vries, a visionary at the intersection of IT and healthcare business strategy. Eduard sha…
  continue reading
 
Creative Biolabs integrates the latest scientific advances in exosomes and makes them into a podcast column. This episode introduces the exosome biogenesis and therapeutics knowledge.antibodybasedpharmaceuticalsresourcelibrary
  continue reading
 
Creative Biolabs integrates the latest scientific advances in exosomes and makes them into a podcast column. This episode introduces the exosome biogenesis and therapeutics knowledge.antibodybasedpharmaceuticalsresourcelibrary
  continue reading
 
Creative Biolabs integrates the latest scientific advances in exosomes and makes them into a podcast column. This episode introduces the exosome biogenesis and therapeutics knowledge.antibodybasedpharmaceuticalsresourcelibrary
  continue reading
 
Creative Biolabs integrates the latest scientific advances in exosomes and makes them into a podcast column. This episode introduces the exosome biogenesis and therapeutics knowledge.antibodybasedpharmaceuticalsresourcelibrary
  continue reading
 
A revolution in biotechnology is underway, with artificial intelligence at its core, but the fervor over AI adoption brings with it pressing concerns about data protection that cannot be overlooked. In this episode, I'm joined by Bob McCowan, Chief Information Officer at Regeneron, to navigate the crossroads of AI development and data security. We …
  continue reading
 
The recent paper published in PLOS ONE presents a novel approach for efficiently retrieving a substantial number of patents related to specific technologies. The authors enhance an automated patent landscaping…SourceDrugPatentWatch
  continue reading
 
Jingsong Wang, Chairman of Nona Biosciences, discusses Nona Biosciences’ recent exclusive license agreement with Pfizer Inc. for the development and commercialization of HBM9033, an innovative antibody-drug conjugate (ADC) targeting MSLN, a key antigen in various solid tumors. Wang believes that the partnership will significantly advance Nona's Har…
  continue reading
 
A recent article published in Health Affairs, delves into the Federal Trade Commission’s (FTC) concerns regarding the inclusion of improper patents in the FDA’s Orange Book by pharmaceutical manufacturers. The…SourceDrugPatentWatch
  continue reading
 
Fran Gregory, VP of Emerging Therapies, Cardinal Health discusses her career, how both CAR-T therapies and personalization have been gaining momentum and what kind of progress we expect to see from them, some of the biggest hurdles facing their section of the industry, the importance of patient advocacy and so much more.…
  continue reading
 
Automation has become a pivotal force in the advancement of the biotech sector, ushering in a new era of AI-driven solutions. In this episode, I'm joined by David Williamson, the CIO at Abzena and a trailblazer in biotech innovation. We're peeling back the layers of AI integration, from commercial chatbots that defy the conventional, to AI's grip o…
  continue reading
 
After decades of development and innovation, Creative Biolabs is committed to demonstrating our strong expertise and capabilities in the field of ribosome research, as well as expanding our research and service capabilities to multiple fields. This five-part video we will briefly introduce ribosome analysis technology, polysome profiling, ribosome …
  continue reading
 
A recent article published in the Journal of Cheminformatics addresses the challenge of confirming the patent status of newly developed compounds, particularly in the pharmaceutical industry, where generating novel structures…SourceDrugPatentWatch
  continue reading
 
Loading …

Короткий довідник